RWE Solutions · Market Access
Market Access Consulting
Market access consulting gets therapies to the patients who need them, turning evidence into reimbursement, pricing and payer agreement.
Meet the market access consultancies, and the teams that hire them, at RWE Connect 2026 in Boston.
No public pricing. Enquiry-led, no obligation.
Capabilities
What Market Access Consulting Delivers
Market access consultancies build the strategy and evidence that move a therapy from approved to reimbursed.
The concepts
Key Market Access Concepts Explained
A handful of concepts underpin almost every access decision. Here is the plain-English version, and where each shows up at RWE Connect.
The challenge
The Barriers, and How Market Access Answers Them
Getting to reimbursement is rarely simple. Good market access strategy turns each barrier into a plan.
The Access Barriers
- Pricing pressure and constrained budgets
- Rising HTA scrutiny
- A fragmented, multi-payer landscape
- Evidence gaps at launch
- Slow reimbursement timelines
How Market Access Answers Them
- A compelling, payer-ready value story
- HTA-ready evidence and dossiers
- Payer-specific access strategy
- Real-world evidence to close gaps
- Faster, smoother submissions
The RWE connection
How Real-World Evidence Strengthens Market Access
Real-world evidence has become central to access. It is where the payer conversation increasingly turns, and a core theme at RWE Connect 2026.
Industry trends
What’s Shaping Market Access in 2026
Access is a moving target as policy and payers evolve. These are the forces reshaping it, and themes on the agenda at RWE Connect 2026.
Who is in the room
Attendee Breakdown
A senior, focused audience of the buyers who own access and reimbursement.
Seniority is confirmed: 150+ attendees, around 60% at Director or VP level and above. The functional mix shown is indicative; confirmed registration splits are shared with sponsors from the live delegate list.
Why RWE Connect
A Generic Access Conference vs RWE Connect
There are plenty of pricing and access conferences. RWE Connect is built around the evidence that increasingly decides access, and the senior buyers who own it.
A Generic Access Conference
- A broad pricing-and-access agenda spread thin
- Buyers mixed in among agencies and vendors
- Lecture format with limited 1:1 access
- Networking left to chance encounters and business cards
- Sponsorship measured in booth footfall and impressions
- Little visibility into who is actually attending
RWE Connect 2026
- A focus on the real-world evidence behind access
- 150+ senior access, HEOR and RWE buyers
- A Partnering Lounge built for pre-scheduled 1:1 meetings
- Meetings booked with the accounts you name
- Sponsorship measured in qualified pipeline, not footfall
- A shared delegate list for warm, targeted follow-up
Why sponsor
Meet the Teams That Own Market Access
What sponsoring looks like
How a Market Access Consultancy Wins Business at RWE Connect
Sponsorship here is built around qualified meetings, not just a stand. This is the typical path from sign-up to signed opportunity.
RWE Connect 2026
Put Your Market Access Practice in Front of the Room
150+ real-world evidence and market-access buyers, around 60% at Director or VP level and above, over two days in Boston. Request the prospectus and the team replies within one business day.
- Exhibition space and capability showcases
- Speaking and panel opportunities
- Pre-scheduled 1:1 meetings with the buyers you name
No public pricing. Enquiry-led, no obligation.
Market Access Consulting: Common Questions
What is market access consulting?
Market access consulting helps therapies reach reimbursement and patients through value proposition, pricing, HTA and payer strategy.
What does a market access consultancy do?
It develops the value proposition and messaging, HTA submissions, pricing strategy, payer engagement, reimbursement strategy and launch and access planning.
How does market access relate to HEOR?
HEOR generates the economic and outcomes evidence; market access turns that evidence into pricing, reimbursement and payer agreement. The two work hand in hand.
How does real-world evidence support market access?
Real-world evidence strengthens the value story, closes evidence gaps at and after launch, and supports HTA submissions and payer negotiations.
What is HTA?
Health technology assessment: the process payers and agencies use to evaluate a therapy’s clinical and economic value before deciding to fund it.
Can my market access company exhibit or sponsor?
Yes. Request the prospectus for exhibition, speaking and pre-scheduled 1:1 meeting options; pricing is shared on enquiry.
When and where is RWE Connect 2026?
14 to 15 October 2026 at the Hampton Inn by Hilton, Boston Seaport District, Boston, MA.
What is a value-based or outcomes-based agreement?
A contract that ties a therapy’s price or rebates to its real-world performance, sharing risk between the manufacturer and the payer.
How is the Inflation Reduction Act changing market access?
It introduces Medicare price negotiation and inflation rebates, reshaping US pricing, launch sequencing and access strategy.
What is the EU Joint Clinical Assessment (JCA)?
A centralized EU clinical assessment that feeds national HTA decisions, phasing in from 2025 to reduce duplicate evaluations across member states.
How is RWE Connect different from a generic market access conference?
RWE Connect focuses on the real-world evidence behind access and gathers senior buyers, with a Partnering Lounge built for pre-scheduled 1:1 meetings and sponsorship measured in pipeline rather than footfall.
What do market access sponsors get at RWE Connect 2026?
Exhibition space and a capability showcase, speaking and panel opportunities, pre-scheduled 1:1 meetings with the accounts you name, the delegate list for follow-up, and brand exposure to 150+ real-world evidence buyers.
